A comprehensive view of Illnesses / Symptoms / Conditions. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Forestry & Timberland Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Regeneron lists Phase 1/2 clinical trial to study REGN10597 in patients with advanced solid organ malignancies; trial aims to evaluate safety, tolerability, and activity of the anti-PD-1-IL2RA-IL2 fusion protein
Published: May 15, 2024 by Contify Life Science News
IL SB1089: Amends the Lead Poisoning Prevention Act with a technical change.
Published: May 15, 2024 by Illinois 103rd General Assembly
NY A04472: Toxic tort cases: Presumes date of injury discovery in toxic tort cases as date of diagnosis.
Published: May 14, 2024 by New York 2023-2024 General Assembly
US Patent Issued to REGENERON PHARMACEUTICALS on May 7 for "Use of a VEGF antagonist to treat angiogenic eye disorders" (New York Inventor)
Published: May 08, 2024 by U.S. Fed News
Researchers Submit Patent Application, 'Patient Response-Based Biomarker Topology Quantification And Assessment For Multiple Tissue Types', for Approval (USPTO 20240127451)
Published: May 08, 2024 by Immunotherapy Daily

Ask us about our Forestry & Timberland market view

Trending Chart

Interactive chart with headline count